miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.

Theranostics · 2019 · PMC6857048 · PMID 31754405

Europe PMC DOI

hedged sentence

0.0622

closest p · 1.2× alpha

0.0622

boldest claim

The sentences

did not reach statistical significanceP =0.0622so close (0.05 < p ≤ 0.1)

In addition, miR-302a expression presented an inverse correlation with NFIB staining ( P =0.0216), but the correlation between miR-302a expression and CD44 staining did not reach statistical significance ( P =0.0622, Figure S4 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.